Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.

Damiani C, Le Gal S, Da Costa C, Virmaux M, Nevez G, Totet A.

J Clin Microbiol. 2013 Oct;51(10):3380-8. doi: 10.1128/JCM.01554-13.

2.

Quantitative real-time PCR and the (1→3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization.

Matsumura Y, Ito Y, Iinuma Y, Yasuma K, Yamamoto M, Matsushima A, Nagao M, Takakura S, Ichiyama S.

Clin Microbiol Infect. 2012 Jun;18(6):591-7. doi: 10.1111/j.1469-0691.2011.03605.x.

3.

Serum (1 → 3) β-D-glucan assay for discrimination between Pneumocystis jirovecii pneumonia and colonization.

Tasaka S, Kobayashi S, Yagi K, Asami T, Namkoong H, Yamasawa W, Ishii M, Hasegawa N, Betsuyaku T.

J Infect Chemother. 2014 Nov;20(11):678-81. doi: 10.1016/j.jiac.2014.07.001.

PMID:
25066434
4.

Usefulness of (1,3) ß-D-glucan detection in bronchoalveolar lavage samples in Pneumocystis pneumonia and Pneumocystis pulmonary colonization.

Damiani C, Le Gal S, Goin N, Di Pizio P, Da Costa C, Virmaux M, Bach V, Stéphan-Blanchard E, Nevez G, Totet A.

J Mycol Med. 2015 Mar;25(1):36-43. doi: 10.1016/j.mycmed.2014.11.001.

PMID:
25498852
5.

Impact of HIV Infection Status on Interpretation of Quantitative PCR for Detection of Pneumocystis jirovecii.

Louis M, Guitard J, Jodar M, Ancelle T, Magne D, Lascols O, Hennequin C.

J Clin Microbiol. 2015 Dec;53(12):3870-5. doi: 10.1128/JCM.02072-15.

6.

Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients.

Huggett JF, Taylor MS, Kocjan G, Evans HE, Morris-Jones S, Gant V, Novak T, Costello AM, Zumla A, Miller RF.

Thorax. 2008 Feb;63(2):154-9. Erratum in: Thorax. 2009 Jul;64(7):643.

PMID:
17693588
7.

Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients.

Maillet M, Maubon D, Brion JP, François P, Molina L, Stahl JP, Epaulard O, Bosseray A, Pavese P.

Eur J Clin Microbiol Infect Dis. 2014 Mar;33(3):331-6. doi: 10.1007/s10096-013-1960-3.

PMID:
23990137
8.

Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients.

Alanio A, Desoubeaux G, Sarfati C, Hamane S, Bergeron A, Azoulay E, Molina JM, Derouin F, Menotti J.

Clin Microbiol Infect. 2011 Oct;17(10):1531-7. doi: 10.1111/j.1469-0691.2010.03400.x.

9.

Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients.

Botterel F, Cabaret O, Foulet F, Cordonnier C, Costa JM, Bretagne S.

J Clin Microbiol. 2012 Feb;50(2):227-31. doi: 10.1128/JCM.06036-11.

10.

(1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients.

Esteves F, Lee CH, de Sousa B, Badura R, Seringa M, Fernandes C, Gaspar JF, Antunes F, Matos O.

Eur J Clin Microbiol Infect Dis. 2014 Jul;33(7):1173-80. doi: 10.1007/s10096-014-2054-6.

PMID:
24487911
11.

Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study.

Robert-Gangneux F, Belaz S, Revest M, Tattevin P, Jouneau S, Decaux O, Chevrier S, Le Tulzo Y, Gangneux JP.

J Clin Microbiol. 2014 Sep;52(9):3370-6. doi: 10.1128/JCM.01480-14.

12.

Pneumocystis polymerase chain reaction and blood (1→3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia.

Matsumura Y, Ito Y, Yamamoto M, Matsushima A, Nagao M, Takakura S, Iinuma Y, Ichiyama S.

J Infect Chemother. 2014 Feb;20(2):109-14. doi: 10.1016/j.jiac.2013.09.004.

PMID:
24480550
13.

Serum and bal beta-D-glucan for the diagnosis of Pneumocystis pneumonia in HIV positive patients.

Salerno D, Mushatt D, Myers L, Zhuang Y, de la Rua N, Calderon EJ, Welsh DA.

Respir Med. 2014 Nov;108(11):1688-95.

14.

[Investigation of Pneumocystis jirovecii in clinical specimens by different methods].

Tekinşen FF, Koç AN.

Mikrobiyol Bul. 2013 Oct;47(4):658-67. Turkish.

15.

Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay.

Hauser PM, Bille J, Lass-Flörl C, Geltner C, Feldmesser M, Levi M, Patel H, Muggia V, Alexander B, Hughes M, Follett SA, Cui X, Leung F, Morgan G, Moody A, Perlin DS, Denning DW.

J Clin Microbiol. 2011 May;49(5):1872-8. doi: 10.1128/JCM.02390-10.

16.
17.

Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study.

Shimizu Y, Sunaga N, Dobashi K, Fueki M, Fueki N, Makino S, Mori M.

BMC Infect Dis. 2009 Apr 22;9:47. doi: 10.1186/1471-2334-9-47.

18.

Association between circulating DNA, serum (1->3)-β-D-glucan, and pulmonary fungal burden in Pneumocystis pneumonia.

Costa JM, Botterel F, Cabaret O, Foulet F, Cordonnier C, Bretagne S.

Clin Infect Dis. 2012 Jul;55(2):e5-8. doi: 10.1093/cid/cis412.

19.

[The Pneumocystis jirovecii colonization in bronchoalveolar lavage (BAL) and bronchial washing and the comparison of methods which are used in diagnosis].

Özmen A, Mıstık R, Alver O, Coşkun F, Ursavaş A, Uzaslan E.

Tuberk Toraks. 2013;61(4):303-11. Turkish.

20.

A highly sensitive novel PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveloar lavage specimens from immunocompromised patients.

Tia T, Putaporntip C, Kosuwin R, Kongpolprom N, Kawkitinarong K, Jongwutiwes S.

Clin Microbiol Infect. 2012 Jun;18(6):598-603. doi: 10.1111/j.1469-0691.2011.03656.x.

Items per page

Supplemental Content

Support Center